Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)

Clinical trial NCT00716625 · COMPLETED

Trial details

NCT number: NCT00716625
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Renal Cell

Start date: 2008-06-01
Primary completion: 2015-10-01
Enrollment: 1674

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.